Phase 1 Locally Advanced Rectal Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer (LARC)

Akamis Bio30 enrolled6 locationsNCT06459869

Recruiting

Phase 1

SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

University of Miami25 enrolled1 locationNCT05412082